Uso de la evidencia durante la pandemia de COVID-19 en el Perú, aportes del Instituto Nacional de Salud

Karen Huaman Sanchez; Fabiola Huaroto; Catherine Bonilla; Adolfo Aramburú; Javier Morales Barrenechea; Ericson L. Gutiérrez; Maricela Curisinche; Daniel Rojas Bolivar; Diana Maria Gonzales Zurita; Jose Carlos Sánchez-Ramírez; Nora Reyes Puma

doi:10.35434/rcmhnaaa.2022.15Supl.1.1542

Uso de la evidencia durante la pandemia de COVID-19 en el Perú, aportes del Instituto Nacional de Salud

Translated title of the contribution: Use of evidence during the COVID-19 pandemic in Peru, contributions from the National Institute of Health

Karen Huaman Sanchez
, Fabiola Huaroto
, Catherine Bonilla
, Adolfo Aramburú
, Javier Morales Barrenechea
, Ericson L. Gutiérrez
, Maricela Curisinche
, Daniel Rojas Bolivar
, Diana Maria Gonzales Zurita
, Jose Carlos Sánchez-Ramírez
, Nora Reyes Puma

Faculty of health sciences

Research output: Contribution to journal › Original Article › peer-review

1 Scopus citations

Abstract

The COVID-19 pandemics required the countries to take decisions rapidly. Consequently, the National Institute of Health (INS) developed a series of documents of scientific evidence synthesis according to the Ministry of Health’s requirements. Based on these reports, the INS developed recommendations to update normative documents related to COVID-19’s management. This article describes the construction of a new methodology applied by the INS to synthesize scientific evidence during the COVID-19 pandemic. Moreover, it emphasizes the efforts and strategies used to guarantee the methodological quality and the implementation of the GRADE approach. Finally, it provides a short reflection on the limitations and challenges of using evidence to design national public policies in the future.

Translated title of the contribution	Use of evidence during the COVID-19 pandemic in Peru, contributions from the National Institute of Health
Original language	Spanish
Journal	Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo
Volume	15
DOIs	https://doi.org/10.35434/rcmhnaaa.2022.15Supl.1.1542
State	Indexed - Sep 2022

Bibliographical note

Publisher Copyright:
© 2022 Publicado por Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo.

Access to Document

10.35434/rcmhnaaa.2022.15Supl.1.1542

Cite this

Sanchez, K. H., Huaroto, F., Bonilla, C., Aramburú, A., Barrenechea, J. M., Gutiérrez, E. L., Curisinche, M., Bolivar, D. R., Zurita, D. M. G., Sánchez-Ramírez, J. C., & Puma, N. R. (2022). Uso de la evidencia durante la pandemia de COVID-19 en el Perú, aportes del Instituto Nacional de Salud. Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo, 15. https://doi.org/10.35434/rcmhnaaa.2022.15Supl.1.1542

@article{83dc207356544ed68a309581c5f7f93c,

title = "Uso de la evidencia durante la pandemia de COVID-19 en el Per{\'u}, aportes del Instituto Nacional de Salud",

abstract = "The COVID-19 pandemics required the countries to take decisions rapidly. Consequently, the National Institute of Health (INS) developed a series of documents of scientific evidence synthesis according to the Ministry of Health{\textquoteright}s requirements. Based on these reports, the INS developed recommendations to update normative documents related to COVID-19{\textquoteright}s management. This article describes the construction of a new methodology applied by the INS to synthesize scientific evidence during the COVID-19 pandemic. Moreover, it emphasizes the efforts and strategies used to guarantee the methodological quality and the implementation of the GRADE approach. Finally, it provides a short reflection on the limitations and challenges of using evidence to design national public policies in the future.",

keywords = "COVID-19, GRADE approach, Per{\'u}, Policy Making, evidence-informed policy-making",

author = "Sanchez, \{Karen Huaman\} and Fabiola Huaroto and Catherine Bonilla and Adolfo Arambur{\'u} and Barrenechea, \{Javier Morales\} and Guti{\'e}rrez, \{Ericson L.\} and Maricela Curisinche and Bolivar, \{Daniel Rojas\} and Zurita, \{Diana Maria Gonzales\} and S{\'a}nchez-Ram{\'i}rez, \{Jose Carlos\} and Puma, \{Nora Reyes\}",

note = "Publisher Copyright: {\textcopyright} 2022 Publicado por Cuerpo M{\'e}dico Hospital Nacional Almanzor Aguinaga Asenjo.",

year = "2022",

month = sep,

doi = "10.35434/rcmhnaaa.2022.15Supl.1.1542",

language = "Espa{\~n}ol",

volume = "15",

journal = "Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo",

issn = "2225-5109",

publisher = "Medical Body of the Almanzor Aguinaga Asenjo National Hospital",

}

Sanchez, KH, Huaroto, F, Bonilla, C, Aramburú, A, Barrenechea, JM, Gutiérrez, EL, Curisinche, M, Bolivar, DR, Zurita, DMG, Sánchez-Ramírez, JC & Puma, NR 2022, 'Uso de la evidencia durante la pandemia de COVID-19 en el Perú, aportes del Instituto Nacional de Salud', Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo, vol. 15. https://doi.org/10.35434/rcmhnaaa.2022.15Supl.1.1542

TY - JOUR

T1 - Uso de la evidencia durante la pandemia de COVID-19 en el Perú, aportes del Instituto Nacional de Salud

AU - Sanchez, Karen Huaman

AU - Huaroto, Fabiola

AU - Bonilla, Catherine

AU - Aramburú, Adolfo

AU - Barrenechea, Javier Morales

AU - Gutiérrez, Ericson L.

AU - Curisinche, Maricela

AU - Bolivar, Daniel Rojas

AU - Zurita, Diana Maria Gonzales

AU - Sánchez-Ramírez, Jose Carlos

AU - Puma, Nora Reyes

PY - 2022/9

Y1 - 2022/9

N2 - The COVID-19 pandemics required the countries to take decisions rapidly. Consequently, the National Institute of Health (INS) developed a series of documents of scientific evidence synthesis according to the Ministry of Health’s requirements. Based on these reports, the INS developed recommendations to update normative documents related to COVID-19’s management. This article describes the construction of a new methodology applied by the INS to synthesize scientific evidence during the COVID-19 pandemic. Moreover, it emphasizes the efforts and strategies used to guarantee the methodological quality and the implementation of the GRADE approach. Finally, it provides a short reflection on the limitations and challenges of using evidence to design national public policies in the future.

AB - The COVID-19 pandemics required the countries to take decisions rapidly. Consequently, the National Institute of Health (INS) developed a series of documents of scientific evidence synthesis according to the Ministry of Health’s requirements. Based on these reports, the INS developed recommendations to update normative documents related to COVID-19’s management. This article describes the construction of a new methodology applied by the INS to synthesize scientific evidence during the COVID-19 pandemic. Moreover, it emphasizes the efforts and strategies used to guarantee the methodological quality and the implementation of the GRADE approach. Finally, it provides a short reflection on the limitations and challenges of using evidence to design national public policies in the future.

KW - COVID-19

KW - GRADE approach

KW - Perú

KW - Policy Making

KW - evidence-informed policy-making

UR - https://www.scopus.com/pages/publications/85152923232

U2 - 10.35434/rcmhnaaa.2022.15Supl.1.1542

DO - 10.35434/rcmhnaaa.2022.15Supl.1.1542

M3 - Artículo original

AN - SCOPUS:85152923232

SN - 2225-5109

VL - 15

JO - Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo

JF - Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo

ER -

Uso de la evidencia durante la pandemia de COVID-19 en el Perú, aportes del Instituto Nacional de Salud

Abstract

Bibliographical note

Access to Document

Fingerprint

Cite this